Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
543.95
+0.63 (0.12%)
At close: Oct 6, 2025, 4:00 PM EDT
544.37
+0.42 (0.08%)
Pre-market: Oct 7, 2025, 4:04 AM EDT
Thermo Fisher Revenue
Thermo Fisher had revenue of $10.86B in the quarter ending June 28, 2025, with 2.98% growth. This brings the company's revenue in the last twelve months to $43.21B, up 2.05% year-over-year. In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$43.21B
Revenue Growth
+2.05%
P/S Ratio
4.78
Revenue / Employee
$345,696
Employees
125,000
Market Cap
205.40B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TMO News
- 5 days ago - Top 15 High-Growth Dividend Stocks For October 2025 - Seeking Alpha
- 5 days ago - Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub - Business Wire
- 5 days ago - Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025 - Business Wire
- 6 days ago - Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - Business Wire
- 6 days ago - Thermo Fisher Scientific Shares Up 3.3% After Power Inflow Signal - Benzinga
- 6 days ago - Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe - Business Wire
- 6 days ago - BenchSci Announces Strategic Partnership with Thermo Fisher Scientific to Create AI-powered Tools to Accelerate R&D Productivity - Business Wire
- 12 days ago - Dr. Park CDMO Selects Thermo Fisher Scientific to Equip New Viral Vector Manufacturing Facility - Business Wire